Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody

Oncotarget

Volumn 6, Issue 7, 2015, Pages 4853-4862

  Hamilton, Duane H ^a   Fernando, Romaine I ^a   Schlom, Jeffrey ^a   Palena, Claudia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brachyury; EMT; Monoclonal antibody; Prognosis marker; Tumor antigen

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 54 1; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRACHYURY; UNCLASSIFIED DRUG; BRACHYURY PROTEIN; FETOPROTEIN; TUMOR ANTIGEN;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; METASTASIS; PROTEIN EXPRESSION; TUMOR CELL LINE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMISTRY; IMMUNOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; RABBIT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PROGNOSIS; RABBITS; T-BOX DOMAIN PROTEINS;

EID: 84924955938     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3086     Document Type: Article

References (39)

1. Kispert A and Herrmann BG. The Brachyury gene encodes a novel DNA binding protein. Embo J. 1993; 12(8):3211-3220.
2. Edwards YH, Putt W, Lekoape KM, Stott D, Fox M, Hopkinson DA and Sowden J. The human homolog T of the mouse T(Brachyury) gene, gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res. 1996; 6(3):226-233.
3. Showell C, Binder O and Conlon FL. T-box genes in early embryogenesis. Dev Dyn. 2004; 229(1):201-218.
4. Wilkinson DG, Bhatt S and Herrmann BG. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature. 1990; 343(6259):657-659.
5. Nibu Y, Jose-Edwards DS and Di Gregorio A. From notochord formation to hereditary chordoma: the many roles of Brachyury. Biomed Res Int. 2013; 2013:826435.
6. Hamilton DH, Litzinger MT, Fernando RI, Huang B and Palena C. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas. Semin Oncol. 2012; 39(3):358-366.
7. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C and Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006; 209(2):157-165.
8. Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De Maglio G, den Bakker MA, Di Francesco L, Kalil RK, Athanasou NA, O'Donnell P, McCarthy EF, et al. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol. 2008; 32(4):572-580.
9. Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM and Kelley MJ. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet. 2009; 41(11):1176-1178.
10. Barresi V, Vitarelli E, Branca G, Antonelli M, Giangaspero F and Barresi G. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis. Am J Surg Pathol. 2012; 36(7):1052-1057.
11. Barresi V, Ieni A, Branca G and Tuccari G. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers. Dis Markers. 2014; 2014:514753.
12. Palena C, Polev DE, Tsang KY, Fernando RI, Litzinger M, Krukovskaya LL, Baranova AV, Kozlov AP and Schlom J. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007; 13(8):2471-2478.
13. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, et al. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res. 2012; 18(14):3868-3879.
14. Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J and Palena C. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest. 2010; 120(2):533-544.
15. Fernando RI, Castillo MD, Litzinger M, Hamilton DH and Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011; 71(15):5296-5306.
16. Palena C, Roselli M, Litzinger MT, Ferroni P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI, Hamilton DH, Jochems C, Tsang KY, Cheng Q, et al. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis. J Natl Cancer Inst. 2014; 106(5). Epub online.
17. Pinto F, Pertega-Gomes N, Pereira MS, Vizcaino JR, Monteiro P, Henrique RM, Baltazar F, Andrade RP and Reis RM. T-box transcription factor Brachyury is associated with prostate cancer progression and aggressiveness. Clin Cancer Res. 2014; 20:4949-4961.
18. Haro A, Yano T, Kohno M, Yoshida T, Koga T, Okamoto T, Takenoyama M and Maehara Y. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma. Ann Surg Oncol. 2013; 20 Suppl 3:S509-516.
19. Larocca C, Cohen JR, Fernando RI, Huang B, Hamilton DH and Palena C. An autocrine loop between TGF-beta1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype. Mol Cancer Ther. 2013; 12(9):1805-1815.
20. Palena C, Hamilton DH and Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 2012; 8(6):713-722.
21. Huang B, Cohen JR, Fernando RI, Hamilton DH, Litzinger MT, Hodge JW and Palena C. The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies. Cell Death Dis. 2013; 4:e682.
22. Hamilton DH, Huang B, Fernando RI, Tsang KY and Palena C. WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition. Cancer Res. 2014; 74(9):2510-2519.
23. Kilic N, Feldhaus S, Kilic E, Tennstedt P, Wicklein D, Wasielewski R, Viebahn C, Kreipe H and Schumacher U. Brachyury expression predicts poor prognosis at early stages of colorectal cancer. Eur J Cancer. 2011; 47(7):1080-1085.
24. Ben-Hamo R, Gidoni M and Efroni S. PhenoNet: identification of key networks associated with disease phenotype. Bioinformatics. 2014; 30(17):2399-2405.
25. Palena C, Fernando RI, Litzinger MT, Hamilton DH, Huang B and Schlom J. Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Exp Biol Med (Maywood). 2011; 236(5):537-545.
26. Hamilton DH, Litzinger MT, Jales A, Huang B, Fernando RI, Hodge JW, Ardiani A, Apelian D, Schlom J and Palena C. Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget. 2013; 4(10):1777-1790.
27. Palena C, Fernando RI and Hamilton DH. An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition. Oncoimmunology. 2014; 3(1):e27220.
28. Open Label Study to Evaluate the Safety and Tolerability of GI-6301 a Vaccine Consisting of Whole Heat-Killed Recombitant Yeast Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors. 2013. Feb 5. http://www.clinicaltrials.gov/ct2/show/NCT01519817.
29. Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM). 2014. Sep 3. http://www.clinicaltrials.gov/ct2/show/NCT02179515.
30. O'Donnell P, Tirabosco R, Vujovic S, Bartlett W, Briggs TW, Henderson S, Boshoff C and Flanagan AM. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skeletal Radiol. 2007; 36(1):59-65.
31. Kalluri R and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-1428.
32. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009; 119(6):1417-1419.
33. Kispert A, Koschorz B and Herrmann BG. The T protein encoded by Brachyury is a tissue-specific transcription factor. Embo J. 1995; 14(19):4763-4772.
34. Imajyo I, Sugiura T, Kobayashi Y, Shimoda M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I and Mori Y. T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol. 2012; 41(6):1985-1995.
35. Tucker JA, Jochems C, Boyerinas B, Fallon J, Greiner JW, Palena C, Rodell TC, Schlom J and Tsang KY. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor invovled in epithelial to mesenchymal transition and metastasis. Cancer Immunol Immunother. 2014; 63(12):1307-1317.
36. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J and Gulley JL. Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol. 2012; 13(5):501-508.
37. Heery CR, Singh H, Marte JL, Madan RA, G.H. OSC, Farsaci B, Rodell TC, Palena C, Schlom J and Gulley JL. NCI experience using yeast-brachyury vaccine (GI-6301) in patients with advanced chordoma. J Clin Oncol 2014; 32:5 s (suppl; abstr 3081).
38. Singh H, Heery CR, Marte JL, Farsaci B, Madan RA, G.H. OSC, Palena C, Rodell TC, Schlom J and Gulley JL. A phase I study of a yeast-based therapeutic cancer vaccine,GI-6301, targeting brachyury in patients with metastatic carcinoma. J Clin Oncol 2014; 32 (suppl; abstr e14026).
39. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013; 339(6119):580-584.